RS

Rakesh Sharma

Director Director DIN 02023866
DIN 02023866 First appointment Feb 2007 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Rakesh Sharma

Data last updated:

Rakesh Sharma was a Director at Visha Pharmaceuticals Private Limited (2007–2008) and Director at Galatro Pharmaceuticals Private Limited (from 2013). The companies operate in Pharma.

DIN 02023866
Primary Designation Director
Industry Pharma
First Appointment 15 Feb 2007
Oldest Company Age 12 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Feb 20072007₹80.3 Lakh (FY 2022)Active
Director27 Nov 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Galatro Pharmaceuticals Private Limited
Visha Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rakesh Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Sharma

Rakesh Sharma was first appointed on 15 Feb 2007 as Director at Visha Pharmaceuticals Private Limited. The most recent appointment on record is 27 Nov 2013 at Galatro Pharmaceuticals Private Limited.

Rakesh Sharma held 2 earlier board appointments: Visha Pharmaceuticals Private Limited (Director, 15 Feb 2007 to 28 Apr 2008); Galatro Pharmaceuticals Private Limited (Director, from 27 Nov 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available